Research and Development Disclosure [Abstract] Research and Development Disclosure [Text Block] LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT Research And Development Disclosure. Investments, Debt and Equity Securities [Abstract] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] INVESTMENTS IN MARKETABLE SECURITIES Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] INVENTORIES Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCRUED EXPENSES Debt Disclosure [Abstract] Debt Disclosure [Text Block] DEBT Stockholders Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] COMMON STOCK WARRANTS Income Tax Disclosure [Abstract] Income Tax Disclosure Text Block INCOME TAXES Statement Of Financial Position [Abstract] Statement [Table] Fair Value Of Warrants [Table] Legal Entity [Axis] Entity [Domain] Statement [Line Items] Assets [Abstract] Assets Assets: Assets Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Marketable Securities, Total Marketable securities (Note 4) Accounts Receivable, Net, Total Accounts receivable, net of allowances of $5 and $28 Accrued Investment Income Receivable Accrued investment income Inventory, Net Inventories, net (Note 5) Net inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Deferred Tax Assets, Gross, Current Other current deferred assets Assets, Current, Total Total current assets Property, Plant and Equipment, Net, Total Property, plant and equipment, net (Note 6) Total property, plant and equipment, net Deferred Finance Costs, Noncurrent, Net Deferred debt issuance costs, net of accumulated amortization of $69 and $- (Note 8) Other Assets Other assets Finite-Lived Intangible Assets, Net Intangible asset, net of accumulated amortization of $155 Assets, Total Total assets Liabilities and Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current [Abstract] Current liabilities: Accounts Payable Current Accounts payable Accrued Liabilities Current Accrued expenses (Note 7) Total Interest Payable, Current Accrued interest Interest - current portion Other Liabilities, Current Other current liabilities Deferred Revenue, Current Deferred revenue Long-term Debt, Current Maturities Current maturities of long-term debt (Note 8) Liabilities, Current, Total Total current liabilities Long-term Debt, Total Long-term debt, net of discount of $281 and $400 (Note 8) Debt, net Long-term Portion of Accrued Interest Long-term portion of accrued interest Long-term portion of accrued interest. Commitments and Contingencies Commitments and contingencies (Note 13) Common Stock Value Common stock: $.01 par value per share; 100,000 shares authorized, 48,848 and 48,325 shares issued and outstanding at 2014 and 2013, respectively Additional Paid In Capital Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive income (loss) Stockholders Equity Attributable to Parent, Total Total stockholders' equity Beginning Balance Ending Balance Stockholders' Equity Attributable to Parent [Abstract] Stockholders’ equity: Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure Text Block COMMITMENTS AND CONTINGENCIES Marketable Securities [Table Text Block] Marketable securities Available-For-Sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block] Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value Fair Value, Assets Measured On Recurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring Basis Schedule of Inventory, Current [Table Text Block] INVENTORIES Schedule Of Accrued Liabilities Table [Text Block] ACCRUED EXPENSES Schedule of Debt [Table Text Block] Schedule of Debt Schedule Of Fair Value Of Warrants [Table Text Block] Schedule Of Fair Value Of Warrants Tabular disclosure of Fair value of warrants using black and scholes option pricing model. Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] COMMON STOCK WARRANTS Disclosure License Development and Commercialization Agreement Additional Information [Abstract] License Development and Commercialization Agreement [Table] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Pivotal Phase Iii Clinical Study [Member] Pivotal Phase III Clinical Study Pivotal Phase Iii Clinical Study [Member] Fdas Approval [Member] Fda's Approval Range [Axis] Range [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Subsidiary, Sale of Stock [Axis] Sale of Stock, Name of Transaction [Domain] Settlement Agreement With Par [Member] Settlement Agreement With Par Settlement Agreement With Par Pfizer Agreement [Member] Pfizer Agreement Pfizer Agreement License Development and Commercialization Agreement [Line Items] License Development and Commercialization Agreement [Line Items] Percentage Of Royalty Percentage of royalty Percentage Of Royalty Payment for Termination Represents the amount of one-time termination payment under the agreement. Patents Expiration Year Patents expiration year Patents Expiration Year. Allowance for Doubtful Accounts Receivable, Current Accounts receivable, net of allowances Accumulated Amortization, Deferred Finance Costs Accumulated amortization, deferred finance aosts Finite-Lived Intangible Assets, Accumulated Amortization Finite-lived intangible assets accumulated amortization Debt Instrument, Unamortized Discount Long-term debt, net of debt discount Debt instrument unamortized discount Beginning of year End of year Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Investment In Marketable Securities Additional Information Detail [Abstract] Investment In Marketable Securities [Table] Investment In Marketable Securities [Line Items] Investment In Marketable Securities [Line Items] Unrealized Gain (Loss) on Securities Unrealized gains on securities Unrealized gains (losses) on securities Investment In Marketable Securities [Abstract] Marketable Securities [Table] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Pooled Investment Fund [Member] Pooled investment fund Exchange Traded Funds [Member] Exchange-traded funds Marketable Securities [Abstract] Marketable securities: Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Corporate bonds — maturing within 1 year Available For Sale Securities Debt Maturities After One Through Three Years Fair Value Corporate bonds — maturing after 1 year and through March 2017 air value of available-for-sale debt securities maturing in the second fiscal year through the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Marketable Securities, Current, Total Total marketable securities Fair Value Available-For-Sale Securities, Continuous Unrealized Loss Position, Fair Value [Abstract] Available For Sale Securities Continuous Unrealized Loss Position Fair Value [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Corporate Bonds [Member] Corporate Bonds Available For Sale Securities Continuous Unrealized Loss Position Fair Value [Line Items] Available For Sale Securities Continuous Unrealized Loss Position Fair Value [Line Items] Available-for-sale Securities, Amortized Cost Basis, Total Cost Available-for-sale Securities, Gross Unrealized Gain, Total Gross Unrealized Gains Available-for-sale Securities, Gross Unrealized Loss, Total Gross Unrealized Losses Assets Measured At Fair Value Or Disclosed At Fair Value On Recurring Basis [Abstract] Assets Measured At Fair Value Or Disclosed At Fair Value On Recurring Basis [Table] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 Segments [Axis] Segments [Domain] Corporate Segment [Member] Corporate bonds Assets Measured At Fair Value Or Disclosed At Fair Value On Recurring Basis [Line Items] Assets Measured At Fair Value Or Disclosed At Fair Value On Recurring Basis [Line Items] Schedule Of Inventory [Table] Inventory [Line Items] Cost of Goods Sold Inventory, Current [Table] Inventory, Raw Materials and Supplies, Gross Raw and packaging materials Inventory, Finished Goods, Gross Finished goods Inventory, Gross Total inventory Inventory Valuation Reserves Less: inventory reserve for finished goods Beginning of year End of year Disclosure Accrued Expenses [Abstract] Disclosure - Accrued Expenses [Abstract] Accounts Payable and Accrued Liabilities [Table] Accounts Payable and Accrued Liabilities [Table] Accounts Payable and Accrued Liabilities [Line Items] Accounts Payable and Accrued Liabilities [Line Items] Accounts Payable and Accrued Liabilities [Line Items] Accrued Professional Fees Current Professional services Other Accrued Liabilities Current Other fees and services Employee Related Liabilities Current Payroll, payroll taxes and benefits Accrued Other Professional Fees Current Clinical and regulatory services Accrued Other Professional Fees, Current Manufacturing Services Costs Contract manufacture services Manufacturing services costs. Accrual For Taxes Other Than Income Taxes Current Property taxes Other Accrued Taxes Current Franchise taxes Other Accrued Taxes Current Schedule of Long-term Debt Instruments [Table] Class of Stock [Axis] Class of Stock [Domain] Prior To December Twenty Seven Two Thousand Fourteen [Member] Prior To December 27 2014 After December Twenty Seven Two Thousand Fourteen But On Or Prior To December Twenty Seven Two Thousand Fifteen [Member] After December 27 2014 but on or prior to December 27, 2015 After To December Twenty Seven Two Thousand Fifteen [Member] After December 27 2015 First Revenue Event Does Not Occurs [Member] First Revenue Event Occurs First Revenue Event Occurs And Second Revenue Event Not Occurs [Member] First Revenue Event Occurs And Second Revenue Event Not Occurs First Revenue Event And Second Revenue Event Occurs [Member] First Revenue Event And Second Revenue Event Occurs Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Warrant Two [Member] Warrant Two Warrant two. Warrant [Member] Warrant Warrant Common stock warrants Subsequent Event Type [Axis] Debt Instrument, Face Amount Debt instrument principal amount Debt Instrument, Interest Rate, Stated Percentage Debt instrument, interest rate, stated percentage Debt Default Long Term Debt Percentage Debt default long term debt percentage Debt default long term debt percentage. Debt Instrument, Maturity Date DebtInstrument PrePayment Percentage Debt instrument prepayment percentage Debt instrument prepayment percentage. Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Debt instrument periodic payment terms balloon payment to be paid Debt Instrument, Fee Amount Debt instrument, fee amount Debt Consulting Placement Fee Debt consulting placement fee Debt consulting placement fee. Debt Related Commitment Fees and Debt Issuance Costs Debt related commitment fees and debt issuance costs Class of Warrant or Right, Outstanding Warrants to purchase common stock Common stock warrant exercisable outstanding, shares Class of Warrant or Right, Exercise Price of Warrants or Rights Class Of Warrant Or Right Expiration Date Warrants, expiry date Common stock Warrant expiration date Class of warrant or right, expiration date. Income Statement [Abstract] Revenues [Abstract] Revenues: Royalty Revenue, Total Royalty revenue Sales Revenue, Goods, Net, Total Product sales, net License and Services Revenue License fee revenue Costs and Expenses [Abstract] Operating expenses: Cost Of Sales Excluding Inventory Write Down Cost of sales (excluding inventory write-down) Cost Of Sales Excluding Inventory Write Down Inventory Write-down Inventory write-down (Note 5) Research and Development Expense, Total Research and development Research and development Selling, General and Administrative Expense, Total Selling, marketing, general and administrative Costs and Expenses, Total Total operating expenses Operating Income (Loss), Total Operating loss Operating loss Nonoperating Income (Expense) [Abstract] Non-Operating income (expense): Investment Income, Nonoperating, Total Investment income Marketable Securities, Gain (Loss), Total Gain on sales of marketable securities Gain on sales of marketable securities Interest Expense, Total Interest expense (Note 8) Total interest expense Nonoperating Income (Expense), Total Total other income (expense), net Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest, Total Loss before income taxes Income Tax Expense (Benefit) Provision for income taxes Provision for income taxes Net Income (Loss) Attributable to Parent, Total Net loss Net loss Numerator: net loss Numerator: net loss Other Comprehensive Income (Loss), Net Of Tax [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Total Total other comprehensive income (loss) Other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive loss Earnings Per Share [Abstract] Loss per share: Earnings Per Share, Basic, Total Basic EPS - basic Earnings Per Share, Diluted, Total Diluted EPS - diluted Diluted loss per share Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract] Weighted average shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Basic, Total Basic Basic weighted average shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted Diluted weighted average shares outstanding Schedule Of Interest Expense [Table] Schedule Of Interest Expense [Line Items]